We are thrilled to invite you to join us at The Thoracic Oncology Group of Australasia (TOGA) Annual Scientific Meeting (ASM) will take place from 31 July to 2 August 2024 at Sheraton Grand Sydney Hyde Park.
Convenor
Dr.
Tracy Leong
- MBBS (Hons) FRACP MPH PhD CCPU
- SpecCertClinLead Director of Bronchoscopy, Respiratory and Sleep Physician, Austin Health, ASM Convenor
“It is my absolute honour and delight to convene the TOGA ASM for 2024 which will promote ‘Charting New Horizons: A Multidisciplinary Approach to Lung Cancer Screening and Care’.
At this exciting time of advances in the field of lung cancer, the TOGA ASM represents a key meeting to learn from international and national experts, develop collaborations with colleagues, and connect with valued members of the lung cancer community.
Together with a stellar multi-disciplinary organising team, I greatly look forward to welcoming you in August to inspire and be inspired.”
International Speakers
The TOGA ASM 2024 program is shaping up to be an exceptional event, featuring a dynamic line-up of speakers. We’re thrilled to confirm participation from both international and local experts:
- International Expertise: Join us for in-person presentations by the esteemed Professors Philip Crosbie and Myung-Ju Ahn.
- Local Insights: Gain valuable perspectives from a diverse range of local speakers tackling a variety of topical issues.
This combination of international and local voices promises a program rich with insights and practical takeaways in thoracic oncology.
Speakers
Program
Note: The agenda topics, speakers and times provided herein may be subject to change
Wednesday 31 July
Thursday 1 August
Friday 2 August
TIME | TOPIC | PRESENTER/S |
---|---|---|
12:00 PM | Registrations | |
01:00 PM | Welcome and Introduction | Dr Tracy Leong |
01:05 PM | Update on National Lung Cancer Screening Program (NLCSP) | Prof Vivienne Milch Ms. Lisa Schofield PSM |
01:15 PM | Impact of NLCSP for Aboriginal and Torres Strait Islander peoples | A/Prof Lisa Whop |
01:25 PM | Impact and Updates related to Respiratory Medicine | Dr Annette McWilliams |
01:40 PM | Impact and Updates related to Radiology | Dr Diane Pascoe |
01:55 PM | Nurse-Led Pulmonary Nodule Clinic | Ms Siobhan Dormer |
02:10 PM | Panel Discussion | All Speakers |
02:40 PM | AFTERNOON TEA | |
03:10 PM | Impact and Updates related to Surgery | A/Prof Gavin Wright |
03:25 PM | The Impact of Lung Cancer Screening on Radiation Oncology | Prof Shalini Vinod |
03:40 PM | Impact and Updates related to Medical Oncology | Dr Malinda Itchins |
03:50 PM | Impact and Updates related to Psycho-Oncology | A/Prof Haryana Dhillon |
04:00 PM | NLCSP Program Guidelines | A/Prof Nicole Rankin |
04:15 PM | Panel Discussion | All Speakers and Anthony Barrett, Consumer Advocate |
04:40 PM | CLOSING | Dr Tracy Leong |
TIME | TOPIC | PRESENTER/S |
---|---|---|
09:00 AM | Registrations | |
09:45 AM | Welcome to Country | |
10:00 AM | Welcome | Dr Tracy Leong |
10:10 AM | Opening Address | Chair: Dr Tracy Leong Mr Anthony Barrett, Consumer Advocate |
10:30 AM | Plenary: Lung Cancer Screening Implementation: A UK Perspective | Chair: Dr Tracy Leong Prof Philip Crosbie |
Additional Considerations for Eligibility in Future Screening Programs Beyond Smoking History | Chair: Dr Tracy Leong | |
11:05 AM | Limitations of the PLCO Model | Dr Annette McWilliams |
11:15 AM | Occupational Lung Disease | Prof Fraser Brims |
11:25 AM | Other Lung Cancer Risk Factors. The Message from TALENT | Prof Emily Stone |
11:35 AM | Panel Discussion | Dr Annette McWilliams Prof Fraser Brims Prof Emily Stone |
11:45 AM | Plenary: Resectable Lung Cancer & Immunotherapy | Chair: Dr Maggie Moore Dr Jessica Donington |
12:20 PM | Protons and Particle Therapy | Chair: Dr Fiona Hegi-Johnson Dr Michelle Li |
12:40 PM | LUNCH | |
01:40 PM | Equitable Access to Quality Care and Clinical Trials | Chair: A/Prof Haryana Dhillon |
01:45 PM | Geriatric Oncology: Striving for the Optimal Management of Thoracic Malignancies in Older Individuals | Dr Michael Krasovitsky |
02:00 PM | Insights into the Barriers and Enablers Influencing Clinical Trial Participation in the Arabic-Speaking Community | Dr Rayan Saleh Moussa |
02:15 PM | Lung Cancer Screening for Aboriginal and Torres Strait Islander Peoples: An Opportunity to Address Health Inequities inequities | A/Prof Lisa Whop |
02:30 PM | Navigating Healthcare in Regional Settings: Challenges and Solutions for Accessing Quality Care | A/Prof Bryan Chan |
02:45 PM | Panel Discussion | Dr Michael Krasovitsky Dr Rayan Saleh Moussa A/Prof Lisa Whop A/Prof Bryan Chan |
03:00 PM | AFTERNOON TEA | |
03:30 PM | Oral Abstracts | Chairs: A/Prof Nicole Rankin Dr Shalini Subramaniam |
03:30 PM | First Sixty Patients in Australia First Lung Cancer Biobank (TRACKER) | Dr Sarah Yeo |
03:45 PM | Impacts of performance status on survival in Small Cell Lung Cancer: Real world evidence from a retrospective registry based cohort study | Dr Wasek Faisal |
04:00 PM | Comparison of 2D and 3D cell culture model as a platform for chemo drug screening in mesothelioma: in vitro and in vivo | Dr. Huaikai (Peter) Shi |
04:15 PM | Lung Cancer Screening using MSAC criteria: a missed opportunity for most | Ms Jacqueline Logan |
04:30 PM | The Long-term Psychosocial Impact in New South Wales Participants of the International Lung Screening Trial (ILST) | Dr Trent Chang-Wei Wu |
04:45 PM | Effect of Rapid Access Lung Cancer Clinic (RALCC) on Timeliness of Diagnosis and Management of Lung Cancer | Dr Cheng Leong Yeo |
05:00 PM | Immunotherapy decision-making in driver-negative, metastatic NSCLC with high PD-L1 expression: Real World Analysis | Dr Samuel Smith |
05:15 PM | Identification of Intrinsic and Extrinsic Factors Contributing to Osimertinib Resistance | Dr Mark Adams |
05:30 PM | FINISH | |
06:30 PM | DINNER |
TIME | TOPIC | PRESENTER/S |
---|---|---|
07:00 AM | Microsatellite Breakfast Symposium Question the Experts- Emerging Clinical Questions when Personalising Treatment in Stage I-III NSCLC Sponsored by Roche | Chair: A/Prof Melissa Moore |
08:00 AM | Registrations | |
08:30 AM | Welcome | Dr Tracy Leong |
08:35 AM | Plenary: Treatment Strategies to Overcome Osimertinib Resistance | Chair: Dr Maggie Moore Prof Myung-Ju Ahn |
09:10 AM | Translational Research from DREAM Clinical Trial | Chair: Prof Nick Pavlakis Dr Melvin Chin |
09:30 AM | Improving Genomic Testing Rates for Inoperable Lung Cancer Patients | Chair: Dr Tracy Leong A/Prof David Fielding |
09:50 AM | Clinical Quality Indicators in Lung Cancer Care | Chair: Ms Amy O’Donnell Prof Fraser Brims |
10:10 AM | Future of Lung Cancer Nursing in Australia | Chair: Dr Vanessa Brunelli Ms Anne Mellon |
10:45 AM | MORNING TEA | |
11:15 AM | TOGA TRIALS | Chair: A/Prof Tom John |
12:45 PM | LUNCH | |
01:45 PM | Membership Meeting | Chairs: Prof Nick Pavlakis |
02:15 PM | Lung Adenocarcinoma Promotion by Air Pollutants | Chair: Dr Tracy Leong Prof Philip Crosbie |
02:35 PM | Recent Updates in Small Cell Lung Cancer | Chair: Prof Nick Pavlakis Prof Myung-Ju Ahn |
02:55 PM | Novel Indications for Surgery in Advanced Stage Lung Cancer | Chair: Dr Christopher Cao Dr Jessica Donington |
03:15 PM | Local Management with Radiotherapy for Oligopersistent and Oligoprogressive Disease after Immunotherapy and TKIs | Chair: Dr Fiona Hegi-Johnson Dr Dasantha Jayamanne |
03:35 PM | The Great Debate | Chair: Prof Michael Boyer |
04:35 PM | Abstract/Poster Awards and Conference Close | Dr Tracy Leong |
04:45 PM | FINISH |
Thank you to our Sponsors
Platinum
Gold
Silver
Bronze
The TOGA 2024 ASM offers a tremendous opportunity to market to one of the largest gatherings of researchers, clinicians, and professionals in the field of lung cancer and thoracic oncology across Australasia. The meeting provides broad company profiling, networking with lead clinicians, and opportunities for future research collaborations.
For more information regarding sponsorship opportunities, please contact:
Dilu Uduwela
Events Manager
E: info@thoraciconcology.org.au